I think my comments are getting taken too literally, because of the way I expressed myself.
I meant it is very hard to sell a product in any hospital because they are all cash strapped, so it has to show a lot of benefit and in some cases it has to be practically all economic benefit. Every product is different so there is no real rule but the example number 1 I described was a product that went 14 for 14 in resolving the problem cost effectively (total bill was like $12,000) and saved 3 of those patients LIVES to boot, yet the bureaucrats said that isn't good enough because it doesn't have data to do what their forms require it to do - they said it requires a cb study. That is in Alberta and mzei is in Ont, so different political rules apply btw.
Perhaps that example doesn't apply to the next product a salesman shows up with but you can get the idea it is a steep hill to climb with a novel product like mzei has if the worst silver bandage sells the best in hospitals because it is cheapest as example number 2. Cleaning up a hospital's HAI problems with one sweep should sell itself in a perfect world but the only perfect world for mzei's product seems to require the US Medicare system where HAI's costs aren't covered.
I didn't even know the product had an Ontario marketing agreement until your post, so I merely guessed when I talked to ir before that it wouldn't sell well in Canada and happened to be LUCKY right with only half the story - whatever I confirmed with ir didn't go into any details that are of interest to your question.
One other mixup in our conversations is defining a cb study - I am referring to a double blinded study where the product is proven to be cost effective with 95% certainty - That requires something like 74 people if the results are overwhelmingly favorable from what I know of one study that went well - I have no idea how you would do a cb study for something like mzei's product but you don't just take one cleaning like they did in Ont and show that room was rid of HAI's for a year afterwards (or whatever the process was) and explain that this would always happen so do the math - likely needs a bunch of successful test occurrences for 95% confidence before a hospital will consider buying it.
